DR. CESARE CEJAS
Founder, Head of Microfluidics
-
5 years experience in microfabrication, microfluidic system design and engineering, prototyping and testing at the Microfluidics, MEMS, and Nanostructures Lab at Ecole Supérieure de Physique et Chimie Industrielle (ESPCI Paris)
-
PhD from Pierre et Marie Curie University in Materials Science (Physics and Chemistry)
-
Post-doctoral researcher for Sanofi (Pharmaceutical Sciences Dept. - Early Development)
DR. JAMES KUSENA
Head of Bioprocessing
-
Experience and PhD in human pluripotent stem cell culture and differentiation from Loughborough University.
-
Experience in cell therapy process development and manufacturing optimisation.
-
Background in Medicinal Chemistry, International Business and Health economics.
NICHOLAS AKOSA
Bioprocessing Scientist
-
3 years experience processing and analysing human cell populations for pharmacodynamic endpoints.
-
2 years experience manufacturing CAR-T cells, including all stages of manufacturing - from starting cells to finished drug product for cancer immunotherapy trials.
-
Background in Biomedical Science.
DR. PAUL SIMMONS
Advisor
-
Head of Research and Product development at Mesoblast
30+ years of experience in stem cell research -
Past president of International Society of Stem Cell Research (ISSCR), C. Harold and Lorine G. Wallace Distinguished Univ.
-
Chair at the Univ. of Texas Health Institute, Inaugural Professor and Director, Centre for Stem Cell Research, Brown Foundation Institute of Molecular Medicine
PROF. TREVOR JONES
Advisor
-
Director of the drug discovery company, e-Therapeutics plc and the life science investment company Arix Bioscience Plc.
-
Boards as Director in the UK: NextPharma Ltd, ReNeuron,BAC BV, Sigma-Tau Finanziaria, Tecnogen SpA, SciClone Inc,and President of Sigma-Tau Pharmaceuticals Inc
-
Chair of the HEVER group